SAINT LOUIS, MO, May 20, 2026 — Modern Med Aesthetics & Wellness announced the introduction of updated neuromodulator assessment workflows for Dysport and Xeomin patients, adding structured facial ...
In a wrinkle-reduction market run by AbbVie’s Botox™ (active ingredient onabotulinumtoxinA), Revance was just approved to distribute DAXXIFY™ (DAXI), a drug that reduces the appearance of facial ...
COLUMBUS, GA, May 18, 2026 — Selah Aesthetics and Wellness announced the introduction of a structured neuromodulator assessment program for patients comparing Xeomin and Botox treatment options. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results